SAHAREK JOHN P. 4
4 · HARROW, INC. · Filed Nov 14, 2023
Insider Transaction Report
Form 4
HARROW, INC.HROW
SAHAREK JOHN P.
CEO & President, ImprimisRx
Transactions
- Exercise/Conversion
Common Stock
2023-11-10+20,000→ 242,197 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-11-10−20,000→ 0 totalExercise: $4.16Exp: 2023-11-12→ Common Stock (20,000 underlying) - Tax Payment
Common Stock
2023-11-10$12.83/sh−9,778$125,452→ 232,419 total
Footnotes (2)
- [F1]Shares withheld to satisfy the exercise price and tax liability incident to the exercise of the stock option. Such withholding did not involve any market sales or other market transactions.
- [F2]The stock option was granted on November 12, 2013 under the Issuers 2007 Stock Incentive and Awards Plan and the shares subject to the stock option became exercisable over a 3 year period following its grant date. The stock option had an expiration date of November 12, 2023.